Characteristics and prevalence of orofacial pain as an initial symptom of oral and oropharyngeal cancer and its impact on the patient?s functionality and quality of life
Carregando...
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, v.134, n.4, p.457-464, 2022
Resumo
Objective. To evaluate the prevalence and characteristics of orofacial pain in oral and oropharyngeal cancer (OOC), at diagnosis.Material and Methods. a) Study group (SG; n = 74) patients with cancer were divided into 2 subgroups: oral cancer (OC) and oro-pharyngeal cancer (OPC); b) control group (CG; n = 74) patients within dental care.Study Design. An Orofacial Pain Assessment, verbal descriptive scale, Helkimo dysfunction index, Quality of Life questionnaire, and Karnofsky performance status (KPS) was used for evaluation.Results. The mean age was 58.46 years (79.7% male) in SG, 58.61 years (20.3% male) in CG. The pain within the SG was indi-cated by the following: prevalence = 91.9% (21.6% in stages 0, I, or II; 70.3% in III or IV); reason for seeking care = 50.1%; main complaint = 55.4%; most important issue in the past 7 days = 74.3%; breakthrough-like pain = 64.9%; main features: chewing or swallowing as triggering factors, wake up patient, variable duration, independent of daytime, multiple descriptors, and earache. The following indexes were worse within the SG: clinical dysfunction, quality of life, and KPS. In addition, the OC subgroup reported toothache-like pain and burning; whereas the OPC subgroup reported heavy swallowing as triggering factor, throat as location, and a bilateral earache.Conclusion. At diagnosis, orofacial pain, including breakthrough-like pain, was prevalent in patients with OOC, and the pattern was heterogeneous. Predominantly, the pain was moderate to severe, related to stage of cancer, and already compromising the patients' quality of life and functionality.
Palavras-chave
Referências
- Benoliel R, 2007, J DENT RES, V86, P491, DOI 10.1177/154405910708600604
- Bhatnagar S, 2010, J PALLIAT MED, V13, P291, DOI 10.1089/jpm.2009.0266
- Charlett SD, 2007, INT J CLIN PRACT, V61, P1015, DOI 10.1111/j.1742-1241.2006.00932.x
- Chaves Thaís Cristina, 2008, Fisioter. Pesqui., V15, P92
- Clark Glenn T, 2008, Dent Clin North Am, V52, P183, DOI 10.1016/j.cden.2007.09.003
- Connelly ST, 2004, J PAIN, V5, P505, DOI 10.1016/j.jpain.2004.09.002
- COUSIN GCS, 1994, BRIT DENT J, V177, P382, DOI 10.1038/sj.bdj.4808618
- Cuffari L, 2006, ORAL SURG ORAL MED O, V102, P56, DOI 10.1016/j.tripleo.2005.10.041
- Datta Sukdeb, 2006, Oral Maxillofac Surg Clin North Am, V18, P627
- Andrade Fabiana Paula de, 2012, Rev. bras. epidemiol., V15, P781, DOI 10.1590/S1415-790X2012000400010
- de Faria Paulo Rogerio, 2003, Clin Oral Investig, V7, P46
- de Leeuw R., 2018, AM ACAD OROFACIAL PA, V6th ed.
- de Siqueira JTT, 2004, ARQ NEURO-PSIQUIAT, V62, P988, DOI 10.1590/S0004-282X2004000600011
- Felippu AWD, 2016, BRAZ J OTORHINOLAR, V82, P140, DOI 10.1016/j.bjorl.2015.10.009
- Dios PD, 2010, ORAL ONCOL, V46, P448, DOI 10.1016/j.oraloncology.2010.02.017
- de Siqueira SRDT, 2020, ARQ NEURO-PSIQUIAT, V78, P321, DOI [10.1590/0004-282X20200003, 10.1590/0004-282x20200003]
- Durazzo Marcelo D., 2005, Clinics, V60, P293, DOI 10.1590/S1807-59322005000400006
- Fakhry C, 2006, J CLIN ONCOL, V24, P2606, DOI 10.1200/JCO.2006.06.1291
- Gorsky M, 2004, ORAL SURG ORAL MED O, V98, P546, DOI 10.1016/j.tripleo.2003.12.041
- Holmes JD, 2003, J ORAL MAXIL SURG, V61, P285, DOI 10.1053/joms.2003.50056
- JAGOX A, 1994, NEW ENGL J MED, V330, P651, DOI 10.1056/NEJM199403033300926
- KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L
- Lam DK, 2011, PAIN, V152, P1206, DOI 10.1016/j.pain.2011.02.009
- Nobrega JCM, 2007, ARQ NEURO-PSIQUIAT, V65, P256, DOI 10.1590/S0004-282X2007000200013
- Marshall J A, 1997, Dent Clin North Am, V41, P355
- MASHBERG A, 1981, CA-CANCER J CLIN, V31, P146, DOI 10.3322/canjclin.31.3.146
- National Cancer Institute, 2018, OR CANC SYMPT
- National Institute of Cancer Brazil, EST 2016 INC CANC BR
- Noonan B, 2014, EUR J ONCOL NURS, V18, P118, DOI 10.1016/j.ejon.2013.07.005
- Park Etern, 2018, Dela J Public Health, V4, P40, DOI 10.32481/djph.2018.01.009
- PAYNE R, 1987, MED CLIN N AM, V71, P153, DOI 10.1016/S0025-7125(16)30863-X
- Pegoraro Douglas Roberto, 2016, Fisioter. mov., V29, P361, DOI 10.1590/0103-5150.029.002.AO15
- Pina P, 2015, PAIN RES MANAG, V20, P249, DOI 10.1155/2015/807432
- PORTENOY RK, 1990, PAIN, V41, P273, DOI 10.1016/0304-3959(90)90004-W
- PORTENOY RK, 1989, CANCER, V63, P2298, DOI 10.1002/1097-0142(19890601)63:11<2298::AID-CNCR2820631140>3.0.CO;2-A
- Portenoy RK, 1999, PAIN, V81, P129, DOI 10.1016/S0304-3959(99)00006-8
- Reyes-Gibby CC, 2014, J PAIN, V15, P1015, DOI 10.1016/j.jpain.2014.07.003
- Robinson PN, 2006, OTOLARYNG CLIN N AM, V39, P295, DOI 10.1016/j.otc.2005.12.001
- Romero-Reyes M, 2016, MED ORAL PATOL ORAL, V21, pE665, DOI 10.4317/medoral.21515
- Rosner B, 1994, FUNDAMENTALS BIOSTAT, V4th
- Ferreira KAS, 2013, PAIN MANAG NURS, V14, P210, DOI 10.1016/j.pmn.2011.04.006
- Schmidt BL, 2015, J ORAL MAXIL SURG, V73, pS132, DOI 10.1016/j.joms.2015.04.045
- Schoenen J, 2001, ACTA NEUROL BELG, V101, P6
- Scully C, 2009, ORAL ONCOL, V45, P301, DOI 10.1016/j.oraloncology.2009.01.004
- Sessle BJ, 2011, INT REV NEUROBIOL, V97, P179, DOI 10.1016/B978-0-12-385198-7.00007-2
- Sobin LH, 2009, TNM CLASSIFICATION M
- Teng WC, 2013, TAIWAN J MAXILLOF SU, V17, P24
- Thoeny H, 2004, EUR RADIOL, V14, P2206, DOI 10.1007/s00330-004-2340-2
- Vartanian JG, 2006, HEAD NECK-J SCI SPEC, V28, P1115, DOI 10.1002/hed.20464
- Viet CT, 2012, J DENT RES, V91, P447, DOI 10.1177/0022034511424156
- Visacri MB, 2015, WSPOLCZESNA ONKOL, V19, P148, DOI 10.5114/wo.2015.51420
- Watson JM, 2009, COMMUNITY DENT ORAL, V37, P333, DOI 10.1111/j.1600-0528.2009.00470.x
- Yang YJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00370-x